MIRA INFORM REPORT

 

 

Report Date :

21.10.2011

 

IDENTIFICATION DETAILS

 

Name :

PEBBLES  PHARMACEUTICAL  LTD.

 

 

Formerly Known As :

HK YONGXIN CHEMICALS LTD.

 

 

Registered Office :

C/o HK Dragon Flying Int’l Invest Consultant Ltd.

Room 5, 6/F., Shun On Commercial Building, 112-114 Des Voeux Road, Central Hong Kong

 

 

Country :

Hong Kong

 

 

Date of Incorporation :

19.10.2010

 

 

Com. Reg. No.:

53123203

 

 

Legal Form :

Private Limited Company.

 

 

Line of Business :

Importer, Exporter and Wholesaler of all kinds of pharmaceuticals, chemicals, etc.

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

Hong Kong 

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name and address

 

PEBBLES  PHARMACEUTICAL  LTD.

 

(Formerly known as HK Yongxin Chemicals Ltd.)

 

Address:          

c/o HK Dragon Flying Int’l Invest Consultant Ltd.

Room 5, 6/F., Shun On Commercial Building,

112-114 Des Voeux Road, Central,

Hong Kong.

 

PHONE:            2869 1893

 

FAX:                 2869 1896

 

 

MANAGEMENT

 

Managing Director:  Mr. Qian Yujie

 

 

SUMMARY

 

Incorporated on:             19th October, 2010.

 

Organization:                 Private Limited Company.

 

Capital:                         Nominal:           HK$10,000,000.00

Issued:              HK$10,000,000.00

 

Business Category:        Importer, Exporter and Wholesaler.

 

Employees:                   Nil.

 

Main Dealing Banker:     The Hongkong & Shanghai Banking Corp. Ltd., Hong Kong.

 

Banking Relation:           Satisfactory.

ADDRESS

 

Registered Head Office:-

c/o HK Dragon Flying Int’l Invest Consultant Ltd.

Room 5, 6/F., Shun On Commercial Building, 112-114 Des Voeux Road, Central, Hong Kong.

 

 

BUSINESS REGISTRATION NUMBER

 

53123203

 

 

COMPANY FILE NUMBER 

 

1517364

 

MANAGEMENT

 

Managing Director:  Mr. Qian Yujie

 

 

CAPITAL

 

Nominal Share Capital: HK$10,000,000.00 (Divided into 10,000,000 shares of HK$1.00 each)

 

Issued Share Capital: HK$10,000,000.00

 

 

SHAREHOLDER

(As per registry dated 28-09-2011)

 

Name

 

No. of shares

QIAN Yujie

 

10,000,000

========

 

 

DIRECTOR    

(As per registry dated 19-10-2010)

 

            Name

            (Nationality)

 

Address

QIAN Yujie

No. 335, Palaestra Road, Xiacheng District, Hangzhou City, Zhejiang Province, China.

 

 

SECRETARY 

(As per registry dated 19-10-2010)

 

Name

Address

Co. No.

HK Dragon Flying Int’l Invest Consultant Ltd.

Room 5, 6/F., Shun On Commercial Building, 112-114 Des Voeux Road, Central Hong Kong.

1126601

 

 

HISTORY

 

The subject was incorporated on 19th October, 2010 as a private limited liability company under the Hong Kong Companies Ordinance.

Originally the subject was registered under the name of HK Yongxin Chemicals Ltd., name changed to the present style on 23rd September, 2011.

Apart from these, neither material change nor amendment has been ever traced and noted.

 

 

OPERATIONS

 

Activities:                      Importer, Exporter and Wholesaler.

 

Lines:                           All kinds of pharmaceuticals, chemicals, etc.

 

Employees:                   Nil.

 

Commodities Imported:   Imports raw materials from European countries, some of the Asian countries and finished products from China.

 

Markets:                       China, Japan, other Asian countries, etc.

 

Terms/Sales:                 L/C, T/T, etc.

 

Terms/Buying:               L/C, T/T, etc.

 

 

FINANCIAL INFORMATION

 

Nominal Share Capital: HK$10,000,000.00 (Divided into 10,000,000 shares of HK$1.00 each)

 

Issued Share Capital: HK$10,000,000.00

 

Alternation of Capital:-

19-10-2010

paid up

HK$      10,000.00

28-09-2011

paid up

HK$      9,990,000.00

 

 

––––––––––––––––

Total:

paid up

HK$10,000,000.00

==============

 

Increase of Nominal Capital:-

From

HK$10,000.00

to

HK$10,000,000.00

 

27-09-2011

 

Profit or Loss:                Too early to offer an opinion.

 

Condition:                      Business is under development.

 

Facilities:                      Making fairly active use of general banking facilities.

 

Payment:                      Met trade commitments as required.

 

Commercial Morality:     Satisfactory

 

Banker:                          The Hongkong & Shanghai Banking Corp. Ltd., Hong Kong.

 

Standing:                      Small.

 

 

GENERAL

 

Having issued 10 million ordinary shares of HK$1.00 each, Pebbles Pharmaceutical Ltd. is wholly owned by Mr. Qian Yujie who is a China merchant.  He is a China ID holder and does not have the right to reside in Hong Kong permanently.  Currently residing in Hangzhou City, Zhejiang Province, China, he is the only director of the subject.

The subject does not have its own operating office.  Its registered office is in a commercial service firm located at ‘Room 5, 6/F., Shun On Commercial Building, 112-114 Des Voeux Road, Central, Hong Kong’ known as ‘HK Dragon Flying Int’l Invest Consultant Ltd.’ [Dragon Flying] which is handling its correspondences and documents.  This firm is also the corporate secretary of the subject.

The subject has no employees in Hong Kong.

Your given phone number 852-3078833 is incorrect as there are only seven digits.  All the phone numbers in Hong Kong are eight-digit.  Your given fax number 2869 1896 belongs to Dragon Flying.

The subject is trading in chemicals and chemical raw materials for manufacturing pharmaceuticals.  Raw materials are imported from Asian countries and Europe.  Prime markets is China.  The subject also exports China-made pharmaceuticals.

It is likely that the subject has got an associated company in Zhejiang Province, China which is also operated by Qian.  The China firm is either a pharmaceutical trading company or a pharmaceutical manufacturing factory.

It is also likely that the China firm deals with foreign parties under the name of the subject and let foreign firms correspond with the subject’s registered address in Hong Kong.  The China firm also exports commodities to foreign markets under the name of the subject and its registered address in Hong Kong.

The subject’s business in Hong Kong is not active.  History in is just over a year.

Since the subject does not have its own operating office and has no employees in Hong Kong, consider it good for business engagements on L/C basis.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.49.71

UK Pound

1

Rs.78.08

Euro

1

Rs.68.05

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.